NICOLE PATTERSON: Open Payments
NPI 1871139014 · CAMBRIDGE CITY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$202 in 12 payments from 9 companies in 2025. Trend: 2023 $432 · 2024 $252 · 2025 $202
Food & beverage: $202
| Company | Payments | Amount |
|---|---|---|
| Esperion Therapeutics, Inc. | 4 | $63 |
| BETA BIONICS, INC. | 1 | $24 |
| PFIZER INC. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
| Verona Pharma, Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: NEXLETOL, iLet Bionic Pancreas, ELIQUIS, FANAPT, JARDIANCE, SHINGRIX, Ozempic, Ohtuvayre.
Industry payments across IN — which companies pay providers there.
